Back to Search Start Over

Small extracellular vesicles derived from adipose mesenchymal stem cells alleviate intestinal fibrosis by inhibiting the FAK/Akt signaling pathway via MFGE8.

Authors :
Xiong Z
Li X
Xie M
Guo J
Yin S
Huang D
Jin L
Wang C
Zhang F
Mao C
Chen H
Luo D
Tang H
Chen X
Lian L
Source :
Journal of gastroenterology [J Gastroenterol] 2024 Dec; Vol. 59 (12), pp. 1092-1106. Date of Electronic Publication: 2024 Sep 21.
Publication Year :
2024

Abstract

Background: Intestinal fibrosis is one of the most frequent and severe complications of Crohn's disease. Accumulating studies have reported that adipose mesenchymal stem cell-derived small extracellular vesicles (AMSC-sEVs) could alleviate renal fibrosis, hepatic fibrosis, etc., while their potential for treating intestinal fibrosis remains uncertain. Therefore, this study aims to determine the therapeutic effects of AMSC-sEVs on intestinal fibrosis and identify the mechanisms underlying these effects.<br />Methods: AMSC-sEVs were characterized using transmission electron microscopy, nanoparticle tracking analysis, and western blot. Whether AMSC-sEVs exert antifibrotic effects was investigated in two different murine models of intestinal fibrosis. Besides, AMSC-sEVs were co-cultured with primary human fibroblasts and CCD18co during transforming growth factor (TGF)-β1 stimulation. Label-free proteomics and rescue experiments were performed to identify candidate molecules in AMSC-sEVs. Transcriptome sequencing revealed changes in mRNA levels among different groups. Lastly, proteins related to relevant signaling pathways were identified by western blotting, and their expression and activation status were assessed.<br />Results: AMSC-sEVs positively expressed CD63 and Alix and presented a classical "rim of a cup" and granule shape with approximately 43-100 nm diameter. AMSCs significantly alleviated intestinal fibrosis through secreted sEVs in vitro and in vivo. The milk fat globule-EGF factor 8 (MFGE8) was stably enriched in AMSC-sEVs and was an active compound contributing to the treatment of intestinal fibrosis by AMSCs. Mechanistically, AMSC-sEV-based therapies attenuated intestinal fibrosis by inhibiting the FAK/Akt signaling pathway.<br />Conclusions: MFGE8-containing AMSC-sEVs attenuate intestinal fibrosis, partly through FAK/Akt pathway inhibition.<br /> (© 2024. Japanese Society of Gastroenterology.)

Details

Language :
English
ISSN :
1435-5922
Volume :
59
Issue :
12
Database :
MEDLINE
Journal :
Journal of gastroenterology
Publication Type :
Academic Journal
Accession number :
39305336
Full Text :
https://doi.org/10.1007/s00535-024-02152-5